Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of GoodRx Holdings, Inc. (GDRX) on Behalf of Investors |

LOS ANGELES, June 1, 2022 /PRNewswire/ — Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, is continuing its investigation on behalf of investors in GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ : GDRX) regarding the Company’s possible violations of federal securities laws.

If you have suffered a loss on your GoodRx investments or would like to inquire about possible lawsuits to recover your loss under federal securities laws, you may submit your contact information at cases/goodrx-holdings-inc-1/. You can also contact Charles H. Linehanof GPM at 310-201-9150, toll free at 888-773-9224, or by email at [email protected] to learn more about your rights.

On May 9, 2022, after the market closed, GoodRx announced its first quarter 2022 financial results and withdrew its guidance for fiscal 2022. In its letter to shareholders, the company said that “a grocery chain has taken steps that had impacted discount acceptance of most PBMs for a subset of drugs”. The company expects that “the grocer issue…could have an estimated revenue impact of approximately $30 million [and] will continue without improvement through the second quarter.” As a result, GoodRx “believes[s] it’s quite unlikely [it] will be able to meet the guidance for fiscal year 2022” previously provided.

On this news, GoodRx’s stock fell $2.78i.e. 25.9%, to close at $7.97 on May 10, 2022thereby harming investors.

Follow us for updates on LinkedIn, Twitteror facebook.

Notice of denunciation: People with nonpublic information about GoodRx should consider their options to help the investigation or take advantage of the SEC’s whistleblower program. Under this program, whistleblowers who provide original information can receive rewards of up to 30% of any successful recovery made by the SEC. For more information contact Charles H. Linehan at 310-201-9150 or 888-773-9224 or email [email protected]

About GPM

Glancy Prongay & Murray LLP is a leading law firm representing investors and consumers in securities litigation and other complex class actions. ISS Securities Class Action Services has consistently ranked GPM in its annual SCAS Top 50 report. In 2018, GPM was ranked among the top five law firms for the number of securities class action settlements and among the top six law firms for the full amount of the settlements. With four offices across the country, nearly 40 GPM attorneys have won groundbreaking decisions and recovered billions of dollars for investors and consumers in securities, antitrust, consumer and employment class action lawsuits. GPM attorneys have handled cases covering a wide range of corporate misconduct, including cases involving financial restatements, internal control weaknesses, earnings management, fraudulent earnings advice and forward-looking statements, audit misconduct, insider trading, violations of FDA regulations, actions resulting in FDA and DOJ investigations, and many other forms of corporate misconduct. GPM’s attorneys have worked on securities matters involving nearly every industry and sector of the capital markets, including energy, consumer discretionary, consumer staples, real estate and REITs, financials, insurance, information technology, healthcare, biotechnology, cryptocurrency, medical devices. , and much more. GPM’s past successes have been widely covered by major industry news and publications such as The Wall Street Journal, The Financial Times, Bloomberg Businessweek, Reutersthe Associated Press, Barrons, Investor’s Business Daily, Forbesand Silver.

This press release may be considered attorney advertising in certain jurisdictions under applicable law and ethics rules.

View original content to download multimedia:–murray-llp-a-leading-securities-fraud-law-firm-continues-its-investigation- of-goodrx-holdings-inc-gdrx-on-behalf-of-investors-301559557.html

THE SOURCE Glancy Prongay & Murray srl